Hologic recently announced the voluntary recall of all unused lots of BioZorb markers and BioZorb LP markers due to reports of serious adverse events (AEs) occurring in patients who had the product ...

In an updated safety communication dated October 25, the FDA states: “The U.S. Food and Drug Administration is alerting consumers, health care providers and health care facilities not to use BioZorb ...

Despite pulling its BioZorb implantable radiographic markers off the market following hundreds of complaints and dozens of reported injuries, the US Food and Drug Administration (FDA) sent a warning ...

The Food and Drug Administration issued a warning letter to Hologic Inc. (NASDAQ:HOLX), citing violations in the manufacturing and reporting processes for its BioZorb product line. The letter, ...

Hologic (NASDAQ:HOLX) has recalled its implantable BioZorb and BioZorb LP Markers over concerns that they can cause irritation, infection and other health complications. The FDA said the devices were ...

On Friday, the FDA warned against using Hologic Inc.’s (NASDAQ:HOLX) BioZorb Marker products and urged healthcare facilities to return all unused lots. This follows Hologic’s voluntary recall of the ...

The FDA warns against BioZorb Markers due to serious side effects, prompting a voluntary recall by Hologic, Inc. BioZorb Markers are used for radiographic marking in soft tissue but are not for ...

The U.S. Food and Drug Administration (FDA) on Wednesday categorized Hologic’s (NASDAQ:HOLX) decision to recall its implantable radiographic marker, BioZorb, as a Class I recall, the agency’s most ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring (Reuters) -The U.S. Food and ...

(Reuters) - The U.S. health regulator on Tuesday warned patients and healthcare providers about the potential risk of serious complications arising from the use of Hologic's devices that are implanted ...

(Reuters) -The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's devices that are implanted in soft tissue such as breast tissue as "most serious", and urged doctors to ...